← brief for 2026-10-03 · Slowing decline

Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center.

Article C Peer reviewed Observational

Key takeaways

This study checked how often doctors prescribe two types of diabetes drugs to patients with heart disease. It looked at records from one large hospital system. This is an observational study, so it shows a link, not proof of cause. It does not test if the drugs work, only if doctors use them.

Who did this work

Avenatti E · Sadhu A · Gullapelli R · Rao A · Pavuluri C · Nasir K · Kashyap SR

Source

Article · PubMed, the drug frontier · 2026 Jul 14
https://pubmed.ncbi.nlm.nih.gov/42827863/